Read + Share
Amedeo Smart
Independent Medical Education
Xu B, Fan Y. CDK4/6 inhibition in early-stage breast cancer: how far is it from becoming standard of care? Lancet Oncol 2021 Jan 15. pii: S1470-2045(20)30757.PMID: 33460573
Email
LinkedIn
Facebook
Twitter
Privacy Policy